Search - tctmd.com

Displaying 501 - 520 of 1023

Sort: Relevancy | Date

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

April 16, 2018

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

News Daily News

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

March 23, 2018

News Industry News

Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System

March 20, 2018

Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4

News Conference News ACC 2018

Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4

March 13, 2018

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

News Conference News ACC 2018

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

March 11, 2018

Varicose Veins Linked to Increased Risk of DVT

News Daily News

Varicose Veins Linked to Increased Risk of DVT

February 28, 2018

A dramatic “cutting” effect during retrograde percutaneous coronary intervention of a chronic total occlusion through an old degenerated venous bypass graft

Presentation JIM 2018

A dramatic “cutting” effect during retrograde percutaneous coronary intervention of a chronic total occlusion through an old degenerated venous bypass graft

Presenter: Gabriele L. Gasparini

February 22, 2018

News Industry News

LivaNova to Acquire TandemLife

February 22, 2018

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

News Conference News ISET 2018

‘Bioconvertible’ IVC Filter Does Its Job Then Moves On: SENTRY Trial

February 15, 2018

PFO Diagnosis Linked With Increased Risk of Perioperative Ischemic Stroke After Noncardiac Surgery

News Daily News

PFO Diagnosis Linked With Increased Risk of Perioperative Ischemic Stroke After Noncardiac Surgery

Yael L. Maxwell

February 07, 2018

Arteriovenous Malformations: Evaluation to Treatment

Presentation ISET 2018

Arteriovenous Malformations: Evaluation to Treatment

Presenter: Paul Rochon

February 04, 2018

DVT and PE Interventions: Case-Based Discussion with the Experts

Presentation ISET 2018

DVT and PE Interventions: Case-Based Discussion with the Experts

Presenter: Brian J. Schiro

February 04, 2018

Pulmonary Arteriovenous Malformations: How to Approach and When to Treat

Presentation ISET 2018

Pulmonary Arteriovenous Malformations: How to Approach and When to Treat

Presenter: Scott Trerotola

February 03, 2018

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

February 01, 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

News Conference News ISC 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

January 27, 2018

Second Arterial vs Venous Conduits for Multivessel CABG in California

Presentation

Second Arterial vs Venous Conduits for Multivessel CABG in California

December 20, 2017

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

News Daily News

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

December 20, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.